| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 SIM1 ZBTB42 CASZ1 ZNF404 ZNF697 ZNF331 ZNF44 | 1.58e-05 | 1412 | 83 | 18 | GO:0000981 |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 6.40e-05 | 19 | 83 | 3 | GO:0031434 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 SIM1 CASZ1 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 8.77e-05 | 1459 | 83 | 17 | GO:0000977 |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 1.88e-04 | 27 | 83 | 3 | GO:0004709 | |
| Domain | - | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 ZBTB42 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 4.95e-09 | 679 | 82 | 17 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 ZBTB42 CASZ1 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 5.27e-09 | 775 | 82 | 18 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 ZBTB42 CASZ1 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 5.48e-09 | 777 | 82 | 18 | PS00028 |
| Domain | zf-C2H2 | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 CASZ1 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 6.71e-09 | 693 | 82 | 17 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 ZBTB42 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 6.85e-09 | 694 | 82 | 17 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 ZBTB42 CASZ1 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 7.98e-09 | 796 | 82 | 18 | IPR015880 |
| Domain | Znf_C2H2 | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 ZBTB42 CASZ1 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 9.50e-09 | 805 | 82 | 18 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 ZBTB42 CASZ1 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 1.01e-08 | 808 | 82 | 18 | SM00355 |
| Domain | RBD | 1.20e-08 | 7 | 82 | 4 | SM00455 | |
| Domain | RBD_dom | 1.20e-08 | 7 | 82 | 4 | IPR003116 | |
| Domain | RBD | 1.20e-08 | 7 | 82 | 4 | PS50898 | |
| Domain | RBD | 1.62e-06 | 6 | 82 | 3 | PF02196 | |
| Domain | KRAB | ZNF630 ZNF527 ZNF605 ZNF283 ZNF778 ZNF808 ZNF213 ZNF404 ZNF331 ZNF44 | 3.71e-06 | 358 | 82 | 10 | PS50805 |
| Domain | KRAB | ZNF630 ZNF527 ZNF605 ZNF283 ZNF778 ZNF808 ZNF213 ZNF404 ZNF331 ZNF44 | 3.71e-06 | 358 | 82 | 10 | PF01352 |
| Domain | KRAB | ZNF630 ZNF527 ZNF605 ZNF283 ZNF778 ZNF808 ZNF213 ZNF404 ZNF331 ZNF44 | 4.85e-06 | 369 | 82 | 10 | SM00349 |
| Domain | KRAB | ZNF630 ZNF527 ZNF605 ZNF283 ZNF778 ZNF808 ZNF213 ZNF404 ZNF331 ZNF44 | 4.97e-06 | 370 | 82 | 10 | IPR001909 |
| Domain | zf-C2H2_6 | 7.07e-05 | 314 | 82 | 8 | PF13912 | |
| Domain | DAG/PE-bd | 1.02e-04 | 21 | 82 | 3 | IPR020454 | |
| Domain | Pkinase_Tyr | 2.59e-04 | 129 | 82 | 5 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.54e-04 | 138 | 82 | 5 | IPR001245 | |
| Domain | Znf_A20 | 3.94e-04 | 7 | 82 | 2 | IPR002653 | |
| Domain | ZF_A20 | 3.94e-04 | 7 | 82 | 2 | PS51036 | |
| Domain | zf-A20 | 3.94e-04 | 7 | 82 | 2 | PF01754 | |
| Domain | ZnF_A20 | 3.94e-04 | 7 | 82 | 2 | SM00259 | |
| Domain | - | 5.24e-04 | 8 | 82 | 2 | 4.10.1110.10 | |
| Domain | zf-AN1 | 5.24e-04 | 8 | 82 | 2 | PF01428 | |
| Domain | ZF_AN1 | 5.24e-04 | 8 | 82 | 2 | PS51039 | |
| Domain | Znf_AN1 | 5.24e-04 | 8 | 82 | 2 | IPR000058 | |
| Domain | ZnF_AN1 | 5.24e-04 | 8 | 82 | 2 | SM00154 | |
| Domain | Growth_fac_rcpt_ | 6.20e-04 | 156 | 82 | 5 | IPR009030 | |
| Domain | Sushi | 1.54e-03 | 52 | 82 | 3 | PF00084 | |
| Domain | CCP | 1.72e-03 | 54 | 82 | 3 | SM00032 | |
| Domain | SUSHI | 1.91e-03 | 56 | 82 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 2.01e-03 | 57 | 82 | 3 | IPR000436 | |
| Domain | C1_1 | 2.01e-03 | 57 | 82 | 3 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 2.80e-03 | 64 | 82 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 2.80e-03 | 64 | 82 | 3 | PS50081 | |
| Domain | C1 | 2.93e-03 | 65 | 82 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 3.06e-03 | 66 | 82 | 3 | IPR002219 | |
| Domain | Ephrin_rec_like | 5.35e-03 | 25 | 82 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.35e-03 | 25 | 82 | 2 | IPR011641 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 3.28e-07 | 14 | 62 | 4 | M47488 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 4.46e-07 | 15 | 62 | 4 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 4.46e-07 | 15 | 62 | 4 | M47473 | |
| Pathway | REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS | 4.47e-06 | 8 | 62 | 3 | M38999 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE | 4.47e-06 | 8 | 62 | 3 | M47933 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY | 9.51e-06 | 10 | 62 | 3 | M47374 | |
| Pathway | KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY | 9.51e-06 | 10 | 62 | 3 | M47420 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY | 9.51e-06 | 10 | 62 | 3 | M47735 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.30e-05 | 11 | 62 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.30e-05 | 11 | 62 | 3 | M47371 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.73e-05 | 12 | 62 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 1.73e-05 | 12 | 62 | 3 | M47597 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 1.73e-05 | 12 | 62 | 3 | M47815 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 2.25e-05 | 13 | 62 | 3 | M47589 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.85e-05 | 14 | 62 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 2.85e-05 | 14 | 62 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.85e-05 | 14 | 62 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.85e-05 | 14 | 62 | 3 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 2.85e-05 | 14 | 62 | 3 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 2.85e-05 | 14 | 62 | 3 | M47384 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47382 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.55e-05 | 15 | 62 | 3 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 4.36e-05 | 16 | 62 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 4.36e-05 | 16 | 62 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 4.36e-05 | 16 | 62 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 4.36e-05 | 16 | 62 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 4.36e-05 | 16 | 62 | 3 | M47801 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 4.36e-05 | 16 | 62 | 3 | M47483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 4.36e-05 | 16 | 62 | 3 | M47682 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 5.27e-05 | 17 | 62 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 5.27e-05 | 17 | 62 | 3 | M47684 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 6.31e-05 | 18 | 62 | 3 | M39737 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 7.47e-05 | 19 | 62 | 3 | M47596 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 7.47e-05 | 19 | 62 | 3 | M47793 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 1.02e-04 | 21 | 62 | 3 | M47792 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 1.29e-04 | 59 | 62 | 4 | M39750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY | 1.35e-04 | 23 | 62 | 3 | M47799 | |
| Pathway | WP_FOCAL_ADHESION | 1.67e-04 | 187 | 62 | 6 | MM15913 | |
| Pathway | WP_NOVEL_JUNDMP1_PATHWAY | 1.74e-04 | 25 | 62 | 3 | MM15984 | |
| Pathway | WP_MAPK_CASCADE | 2.45e-04 | 28 | 62 | 3 | MM15976 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 2.50e-04 | 70 | 62 | 4 | M13266 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.50e-04 | 70 | 62 | 4 | M3115 | |
| Pathway | KEGG_MELANOMA | 2.64e-04 | 71 | 62 | 4 | M15798 | |
| Pathway | WP_PILOCYTIC_ASTROCYTOMA | 2.82e-04 | 6 | 62 | 2 | M39584 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 2.82e-04 | 6 | 62 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 2.82e-04 | 6 | 62 | 2 | MM15273 | |
| Pathway | WP_MAPK_CASCADE | 4.02e-04 | 33 | 62 | 3 | M39594 | |
| Pathway | REACTOME_RAF_ACTIVATION | 4.40e-04 | 34 | 62 | 3 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 4.80e-04 | 35 | 62 | 3 | MM15271 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 4.80e-04 | 35 | 62 | 3 | M47379 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 4.81e-04 | 83 | 62 | 4 | M39637 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 5.03e-04 | 84 | 62 | 4 | M39839 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 5.24e-04 | 8 | 62 | 2 | MM15197 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 6.61e-04 | 39 | 62 | 3 | MM15272 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 7.10e-04 | 92 | 62 | 4 | M47927 | |
| Pathway | WP_BLADDER_CANCER | 7.13e-04 | 40 | 62 | 3 | M39523 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 7.13e-04 | 40 | 62 | 3 | M27557 | |
| Pathway | WP_MAPK_SIGNALING | 7.22e-04 | 246 | 62 | 6 | M39597 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 8.23e-04 | 42 | 62 | 3 | MM15274 | |
| Pathway | KEGG_BLADDER_CANCER | 8.23e-04 | 42 | 62 | 3 | M19096 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 8.82e-04 | 43 | 62 | 3 | M27560 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 1.01e-03 | 45 | 62 | 3 | M27623 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 1.54e-03 | 52 | 62 | 3 | M19877 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.63e-03 | 115 | 62 | 4 | M9387 | |
| Pathway | PID_TCR_RAS_PATHWAY | 1.67e-03 | 14 | 62 | 2 | M134 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 1.67e-03 | 14 | 62 | 2 | MM15198 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 1.71e-03 | 54 | 62 | 3 | M19818 | |
| Pathway | WP_FOCAL_ADHESION | 1.80e-03 | 199 | 62 | 5 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.80e-03 | 199 | 62 | 5 | M7253 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 1.93e-03 | 15 | 62 | 2 | M27456 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 2.00e-03 | 57 | 62 | 3 | M19888 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 2.20e-03 | 16 | 62 | 2 | M39882 | |
| Pathway | KEGG_COLORECTAL_CANCER | 2.55e-03 | 62 | 62 | 3 | M14631 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 2.67e-03 | 63 | 62 | 3 | M39623 | |
| Pathway | KEGG_GLIOMA | 2.91e-03 | 65 | 62 | 3 | M1835 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 2.91e-03 | 65 | 62 | 3 | M38994 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.98e-03 | 325 | 62 | 6 | M12868 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 3.31e-03 | 68 | 62 | 3 | M48322 | |
| Pathway | WP_MELANOMA | 3.31e-03 | 68 | 62 | 3 | M39811 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 3.60e-03 | 70 | 62 | 3 | M8232 | |
| Pathway | KEGG_PANCREATIC_CANCER | 3.60e-03 | 70 | 62 | 3 | M9726 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 3.79e-03 | 21 | 62 | 2 | MM15347 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 3.79e-03 | 21 | 62 | 2 | M27645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 3.79e-03 | 21 | 62 | 2 | M47950 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 3.89e-03 | 72 | 62 | 3 | M39738 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 4.05e-03 | 73 | 62 | 3 | M321 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 4.05e-03 | 73 | 62 | 3 | M39758 | |
| Pubmed | RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. | 1.31e-08 | 3 | 83 | 3 | 20130576 | |
| Pubmed | Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. | 1.31e-08 | 3 | 83 | 3 | 14688025 | |
| Pubmed | Expression of raf family proto-oncogenes in normal mouse tissues. | 1.31e-08 | 3 | 83 | 3 | 1690378 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 9207797 | ||
| Pubmed | Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling. | 1.31e-08 | 3 | 83 | 3 | 23352452 | |
| Pubmed | Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. | 1.31e-08 | 3 | 83 | 3 | 10704835 | |
| Pubmed | ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers. | 1.31e-08 | 3 | 83 | 3 | 22926515 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 8394352 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 8621729 | ||
| Pubmed | Aberrant expression of COT is related to recurrence of papillary thyroid cancer. | 5.23e-08 | 4 | 83 | 3 | 25674762 | |
| Pubmed | B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222. | 5.23e-08 | 4 | 83 | 3 | 7731720 | |
| Pubmed | Functional characterization of a PROTAC directed against BRAF mutant V600E. | 5.23e-08 | 4 | 83 | 3 | 32778845 | |
| Pubmed | Germline gain-of-function mutations in RAF1 cause Noonan syndrome. | 1.31e-07 | 5 | 83 | 3 | 17603482 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 17219248 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 24746704 | ||
| Pubmed | Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. | 2.61e-07 | 6 | 83 | 3 | 8157000 | |
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 19667065 | ||
| Pubmed | AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness. | 1.09e-06 | 9 | 83 | 3 | 30595535 | |
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 17967876 | ||
| Pubmed | Essential role of B-Raf in ERK activation during extraembryonic development. | 1.55e-06 | 10 | 83 | 3 | 16432225 | |
| Pubmed | K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling. | 4.68e-06 | 14 | 83 | 3 | 31015455 | |
| Pubmed | 4.68e-06 | 14 | 83 | 3 | 28073913 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24030394 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20047953 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 36766785 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 37945738 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22514273 | ||
| Pubmed | Mammalian Ras interacts directly with the serine/threonine kinase Raf. | 5.63e-06 | 2 | 83 | 2 | 8334704 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25096573 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22826437 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 38741428 | ||
| Pubmed | B-Raf and C-Raf are required for melanocyte stem cell self-maintenance. | 5.63e-06 | 2 | 83 | 2 | 23022482 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17018604 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25783894 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22833462 | ||
| Pubmed | Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody. | 5.63e-06 | 2 | 83 | 2 | 23208509 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21836066 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30764693 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18205709 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27240957 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29145717 | ||
| Pubmed | Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. | 5.63e-06 | 2 | 83 | 2 | 15035987 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24473438 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22972916 | ||
| Pubmed | LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. | 5.63e-06 | 2 | 83 | 2 | 17178829 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27188183 | ||
| Pubmed | B-Raf and Raf-1 are regulated by distinct autoregulatory mechanisms. | 5.63e-06 | 2 | 83 | 2 | 15710605 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9441754 | ||
| Pubmed | BRAF splice variants in rheumatoid arthritis synovial fibroblasts activate MAPK through CRAF. | 5.63e-06 | 2 | 83 | 2 | 23517740 | |
| Pubmed | Ablation of Ctrp9, Ligand of AdipoR1, and Lower Number of Cone Photoreceptors in Mouse Retina. | 5.63e-06 | 2 | 83 | 2 | 35575905 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30426302 | ||
| Pubmed | CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells. | 5.63e-06 | 2 | 83 | 2 | 29749459 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26419929 | ||
| Pubmed | CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages. | 5.63e-06 | 2 | 83 | 2 | 31837806 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27431613 | ||
| Pubmed | Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells. | 5.63e-06 | 2 | 83 | 2 | 25473895 | |
| Pubmed | RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation. | 5.63e-06 | 2 | 83 | 2 | 23680146 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28978553 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16172610 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21577205 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32831639 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20978199 | ||
| Pubmed | Essential, non-redundant roles of B-Raf and Raf-1 in Ras-driven skin tumorigenesis. | 5.63e-06 | 2 | 83 | 2 | 22733131 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32283037 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11325826 | ||
| Pubmed | RAF inhibitors that evade paradoxical MAPK pathway activation. | 5.63e-06 | 2 | 83 | 2 | 26466569 | |
| Pubmed | CTRP9 Promotes Brown Adipose Tissue Lipolysis in Mice Fed a High-Fat Diet. | 5.63e-06 | 2 | 83 | 2 | 38940054 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26646323 | ||
| Pubmed | C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure. | 5.63e-06 | 2 | 83 | 2 | 27821723 | |
| Pubmed | Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma. | 5.63e-06 | 2 | 83 | 2 | 23802768 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26754066 | ||
| Pubmed | CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. | 5.63e-06 | 2 | 83 | 2 | 18794803 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15856007 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27325282 | ||
| Pubmed | Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. | 5.63e-06 | 2 | 83 | 2 | 16364920 | |
| Pubmed | CTRP9 alleviates foam cells apoptosis by enhancing cholesterol efflux. | 5.63e-06 | 2 | 83 | 2 | 33352225 | |
| Pubmed | Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation. | 5.63e-06 | 2 | 83 | 2 | 30224486 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35008006 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 31930700 | ||
| Pubmed | Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib. | 1.69e-05 | 3 | 83 | 2 | 24486585 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 35115674 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 32944951 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 27529678 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 10454553 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 28806393 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 21122381 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 25870106 | ||
| Pubmed | Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. | 1.69e-05 | 3 | 83 | 2 | 23934108 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 22510884 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26216473 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 19638574 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20052757 | ||
| Pubmed | ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts. | 1.69e-05 | 3 | 83 | 2 | 16861903 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 17635919 | ||
| Pubmed | KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas. | 1.69e-05 | 3 | 83 | 2 | 33046021 | |
| Pubmed | CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. | 1.69e-05 | 3 | 83 | 2 | 23842676 | |
| Pubmed | Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. | 1.69e-05 | 3 | 83 | 2 | 20141835 | |
| Pubmed | ERK and PDE4 cooperate to induce RAF isoform switching in melanoma. | 1.69e-05 | 3 | 83 | 2 | 21478863 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30978318 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 29925877 | ||
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF438 ZNF630 ZBTB38 ZNF527 ZNF605 ZNF341 ZNF283 ZNF778 ZNF808 ZNF76 ZNF213 ZBTB42 CASZ1 ZNF835 ZNF404 ZNF697 ZNF331 ZNF44 | 9.66e-11 | 718 | 68 | 18 | 28 |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 5.06e-07 | 5 | 68 | 3 | 1157 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 9.73e-05 | 24 | 68 | 3 | 654 | |
| GeneFamily | Zinc fingers AN1-type|UPF1 like RNA helicases | 3.85e-04 | 8 | 68 | 2 | 63 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.29e-03 | 57 | 68 | 3 | 1179 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 2.05e-03 | 18 | 68 | 2 | 1372 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.27e-03 | 26 | 68 | 2 | 253 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-08 | 191 | 83 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 194 | 83 | 6 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-06 | 198 | 83 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-05 | 162 | 83 | 5 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 170 | 83 | 5 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.86e-05 | 174 | 83 | 5 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.86e-05 | 174 | 83 | 5 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.86e-05 | 174 | 83 | 5 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.86e-05 | 174 | 83 | 5 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.96e-05 | 176 | 83 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 86 | 83 | 4 | d20ec61a572b11641647358a546334b217c694f3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-05 | 181 | 83 | 5 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 183 | 83 | 5 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 183 | 83 | 5 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.49e-05 | 185 | 83 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.56e-05 | 186 | 83 | 5 | 927723ad579bbd9947ff525bd501e222d3fa9289 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-05 | 186 | 83 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-05 | 186 | 83 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 187 | 83 | 5 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 190 | 83 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.83e-05 | 190 | 83 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 190 | 83 | 5 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-05 | 191 | 83 | 5 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 194 | 83 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 194 | 83 | 5 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.21e-05 | 195 | 83 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 195 | 83 | 5 | 25703e3c2e0512ef12e7aa389fad3968c3f13905 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-05 | 195 | 83 | 5 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 196 | 83 | 5 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 197 | 83 | 5 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.37e-05 | 197 | 83 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-05 | 197 | 83 | 5 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Control-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.37e-05 | 197 | 83 | 5 | b86385c6c1d52ef4e3d855004d77afab61556978 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-05 | 198 | 83 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.53e-05 | 199 | 83 | 5 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 199 | 83 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | Mild/Remission-B_memory-3|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.53e-05 | 199 | 83 | 5 | 493d043beef70b60338cc199db82592cdc6e635d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 42 | 83 | 3 | 56bbec86001d43cc2c71d4dcd70b22ea41963fad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 132 | 83 | 4 | 97e7d5f7086c6213aec4eaa581bc182338189029 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.19e-04 | 135 | 83 | 4 | 54b2aaf8d322e01a3ff6099c2422d68ecccf96b4 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 53 | 83 | 3 | 5fa009c9f30c77de6cece40a47da46241f1de54c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 53 | 83 | 3 | 52a1f2a041e3ba2b11ed753f2f57b78e68b5cc0c | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 146 | 83 | 4 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.60e-04 | 146 | 83 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-04 | 147 | 83 | 4 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 151 | 83 | 4 | 16fc903fc71e25717b9908416f0bcd29c0a65a61 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-04 | 153 | 83 | 4 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.22e-04 | 159 | 83 | 4 | 08a1cd71eac4322fb313324f74fe8e37998f2d7d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 159 | 83 | 4 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.22e-04 | 159 | 83 | 4 | c64fff8d89f84d1f5a0cc432e31f56f741162505 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.22e-04 | 159 | 83 | 4 | 9bdfa7f5aa7753fe25b787bd43d694b6093d77eb | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.27e-04 | 160 | 83 | 4 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.27e-04 | 160 | 83 | 4 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.27e-04 | 160 | 83 | 4 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-04 | 162 | 83 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.50e-04 | 164 | 83 | 4 | f0499e6c1b17c4df72b18b294e3b53ef723da2ac | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 165 | 83 | 4 | 35a6de30438de364ccca948fc932da541a69ef89 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 166 | 83 | 4 | 35db3022c33d6f8bb6587d9eec89a7cccb70271a | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.87e-04 | 170 | 83 | 4 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 2.87e-04 | 170 | 83 | 4 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.87e-04 | 170 | 83 | 4 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 170 | 83 | 4 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 170 | 83 | 4 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.93e-04 | 171 | 83 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-04 | 171 | 83 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.93e-04 | 171 | 83 | 4 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.93e-04 | 171 | 83 | 4 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 83 | 4 | 3c51e7bda1835c25915e50c801b0d643979971a3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 83 | 4 | a042f78a4c69fcc6b5ca76e9bf01e34cee54c81c | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 3.13e-04 | 174 | 83 | 4 | 390bd41ef114464f3db3e0cac4e67fe7571b4c23 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.13e-04 | 174 | 83 | 4 | b1bcd5f4505d2ccef4183fcfbf1de81964b3f9e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-04 | 174 | 83 | 4 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 175 | 83 | 4 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 175 | 83 | 4 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 176 | 83 | 4 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(INS+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-04 | 176 | 83 | 4 | 6b04672f295d7680ba00714a72785314a619c893 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 177 | 83 | 4 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-04 | 177 | 83 | 4 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 178 | 83 | 4 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 3.48e-04 | 179 | 83 | 4 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-04 | 179 | 83 | 4 | d0fa700648db8ce76a8aa689879a25048299fa40 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.48e-04 | 179 | 83 | 4 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-04 | 179 | 83 | 4 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 3.48e-04 | 179 | 83 | 4 | 83506e00fe99b6450efd2f13f716926a0a4b03cd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-04 | 179 | 83 | 4 | 2e49b215b71438400aebb483f2c2c08d5e956961 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.56e-04 | 180 | 83 | 4 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.56e-04 | 180 | 83 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.56e-04 | 180 | 83 | 4 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 180 | 83 | 4 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | Severe-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.56e-04 | 180 | 83 | 4 | 90b812c5450359b1745b413421b71e291c97086a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 180 | 83 | 4 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 180 | 83 | 4 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.63e-04 | 181 | 83 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 181 | 83 | 4 | 46c428037b6eac605635e20e8cc78bce744b4daa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 181 | 83 | 4 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.63e-04 | 181 | 83 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-04 | 182 | 83 | 4 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| Disease | skin disease (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:37 (implicated_via_orthology) | |
| Disease | Noonan syndrome with multiple lentigines | 2.23e-05 | 3 | 81 | 2 | cv:C0175704 | |
| Disease | Leopard Syndrome 1 | 1.11e-04 | 6 | 81 | 2 | C4551484 | |
| Disease | Pilomyxoid astrocytoma | 1.55e-04 | 7 | 81 | 2 | C1519086 | |
| Disease | high grade glioma (implicated_via_orthology) | 2.43e-04 | 44 | 81 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of kidney | 2.60e-04 | 45 | 81 | 3 | C0740457 | |
| Disease | Noonan syndrome | 2.65e-04 | 9 | 81 | 2 | cv:C0028326 | |
| Disease | Turner Syndrome, Male | 4.03e-04 | 11 | 81 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 4.03e-04 | 11 | 81 | 2 | C1527404 | |
| Disease | Noonan Syndrome 1 | 4.03e-04 | 11 | 81 | 2 | C4551602 | |
| Disease | Breast Carcinoma | 7.00e-04 | 538 | 81 | 7 | C0678222 | |
| Disease | RASopathy | 7.64e-04 | 15 | 81 | 2 | cv:C5555857 | |
| Disease | Malignant Glioma | 9.55e-04 | 70 | 81 | 3 | C0555198 | |
| Disease | mixed gliomas | 9.55e-04 | 70 | 81 | 3 | C0259783 | |
| Disease | Benign neoplasm of stomach | 9.85e-04 | 17 | 81 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 9.85e-04 | 17 | 81 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 9.85e-04 | 17 | 81 | 2 | C0154060 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 9.96e-04 | 71 | 81 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.23e-03 | 19 | 81 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 1.23e-03 | 19 | 81 | 2 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.23e-03 | 19 | 81 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.23e-03 | 19 | 81 | 2 | C1275081 | |
| Disease | colorectal adenoma (is_marker_for) | 1.37e-03 | 20 | 81 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 1.37e-03 | 20 | 81 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Stomach Carcinoma | 1.51e-03 | 21 | 81 | 2 | C0699791 | |
| Disease | urinary albumin to creatinine ratio | 1.51e-03 | 179 | 81 | 4 | EFO_0007778 | |
| Disease | LEOPARD Syndrome | 1.66e-03 | 22 | 81 | 2 | C0175704 | |
| Disease | Glioma | 1.79e-03 | 87 | 81 | 3 | C0017638 | |
| Disease | vitronectin measurement | 1.81e-03 | 23 | 81 | 2 | EFO_0021843 | |
| Disease | Carcinoma of lung | 1.81e-03 | 23 | 81 | 2 | C0684249 | |
| Disease | Noonan Syndrome | 1.98e-03 | 24 | 81 | 2 | C0028326 | |
| Disease | Cerebral Astrocytoma | 2.14e-03 | 25 | 81 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.14e-03 | 25 | 81 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 2.14e-03 | 25 | 81 | 2 | C0334583 | |
| Disease | Astrocytoma | 2.14e-03 | 25 | 81 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 2.14e-03 | 25 | 81 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 2.14e-03 | 25 | 81 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 2.14e-03 | 25 | 81 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.14e-03 | 25 | 81 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.14e-03 | 25 | 81 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 2.14e-03 | 25 | 81 | 2 | C0338070 | |
| Disease | Lymphatic Metastasis | 2.32e-03 | 26 | 81 | 2 | C0024232 | |
| Disease | Gemistocytic astrocytoma | 2.32e-03 | 26 | 81 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 2.32e-03 | 26 | 81 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 2.32e-03 | 26 | 81 | 2 | C0334582 | |
| Disease | Adenocarcinoma of large intestine | 2.37e-03 | 96 | 81 | 3 | C1319315 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 2.50e-03 | 27 | 81 | 2 | DOID:0050861 (is_marker_for) | |
| Disease | Anaplastic astrocytoma | 2.50e-03 | 27 | 81 | 2 | C0334579 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.52e-03 | 206 | 81 | 4 | C0152013 | |
| Disease | mean arterial pressure | 2.53e-03 | 499 | 81 | 6 | EFO_0006340 | |
| Disease | HbA1c measurement | 2.56e-03 | 675 | 81 | 7 | EFO_0004541 | |
| Disease | functional brain measurement, language measurement | 2.69e-03 | 28 | 81 | 2 | EFO_0007797, EFO_0007849 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQGFRCQTCGYKFHQ | 256 | P15056 | |
| IHFGCNAGYRLVGHS | 2491 | Q7Z408 | |
| KYIARFSGSQHCGHI | 466 | Q86V15 | |
| QFYGQKTTHFHCRRP | 601 | Q86V15 | |
| HNQAKNLLCGFYGRH | 56 | P31941 | |
| GRQGTCHFFANKYSF | 1636 | P53420 | |
| HRNFHGCLENLYYNG | 326 | Q9C0A0 | |
| AGFFHTGHQDKVRCF | 111 | Q96CA5 | |
| FRQINDHFHVKGCSY | 271 | Q86UB2 | |
| FHQYAQGLFTNCVHG | 1171 | Q6XZF7 | |
| QGLFTNCVHGYAEAH | 1176 | Q6XZF7 | |
| HGHSQKKNVFLYGCS | 901 | Q96MI9 | |
| NGFRCQTCGYKFHEH | 161 | P04049 | |
| GQEKYHSVCHLYFRG | 76 | Q9H0T7 | |
| QNQGYTHFCRGGHFR | 151 | Q8WV74 | |
| QFFYRHGIKRTHNIC | 121 | Q6WBX8 | |
| IHHGRLQYKFDCGSG | 3881 | Q14517 | |
| FEHFQAKTIGHTYCA | 171 | Q6IF63 | |
| HEGRYQCVITNHFGS | 571 | Q96JA1 | |
| NEGHISHFQGKYRCF | 96 | O00533 | |
| QHEHIVKFYGVCGDG | 596 | Q16288 | |
| SHFFQLKNISFCGYH | 636 | Q9UQF2 | |
| DHREIGHGACFSQAY | 86 | Q9H340 | |
| HGCNIFDHFSRKDYQ | 741 | O00408 | |
| YHAGFNHGFNCAEAI | 276 | B2RXH2 | |
| LYHTEGEHCQFCRFG | 1001 | P07942 | |
| SAYHKFLGEVHCGTN | 636 | Q9Y2J8 | |
| YFHFFNISLCGHEGK | 711 | A8MWY0 | |
| FGHKFGDRCGHQENV | 446 | Q9NYA4 | |
| FYQDGKIHCGRHHAE | 171 | Q96MT3 | |
| FNHYDTAAGKFTCHI | 231 | P0C862 | |
| GCEFNQVHYHNGQVF | 121 | O95389 | |
| YLFQIINGIGFCHSH | 106 | Q92772 | |
| HGIKVVSYGDCFDHF | 281 | Q9NWS6 | |
| HGFRCQTCGYKFHQH | 121 | P10398 | |
| GAFLHKGSFCRNYFN | 976 | Q13936 | |
| YKGHCFRINHFPEDN | 76 | Q9UBN1 | |
| FHDRFCQQYNKGIGG | 681 | Q53R41 | |
| FNHYDTAVGKFTCHI | 231 | B2RNN3 | |
| GYRGFQYVLECDHHS | 156 | P53673 | |
| KGHYANRCTKGHLAF | 251 | O95639 | |
| VCDGQYLHNFQCKHG | 491 | P51530 | |
| RDNFDKRSCHYEHGG | 36 | Q9GZY0 | |
| RGHFGCVYHGTLLDN | 1086 | P08581 | |
| FKYRCQNLFGHEGGS | 11 | O75159 | |
| PNCFGSHRQYFDKHA | 696 | P81133 | |
| CHEVHLAGFKYNFSD | 271 | Q9Y274 | |
| NYNIFFHLLKHCFGR | 316 | Q9H5Q4 | |
| YHDVGLNHKLCFNTF | 36 | Q9ULP0 | |
| HAGAYHCFSEEQGAR | 621 | Q9C0C4 | |
| NGFSFIHGGHIQYQC | 2961 | Q4LDE5 | |
| FGQEVYCHLRKEGHE | 11 | O75891 | |
| FLQEFCKKYGGVSHH | 181 | Q7L1S5 | |
| YGDKCQFAHGIHELR | 131 | Q07352 | |
| GGFKKFYFHQHLCIL | 26 | Q96HI0 | |
| HQRAHTGNYKFRCAG | 701 | Q9BYN7 | |
| CGGFYLLNEHGKTHT | 346 | Q96MU6 | |
| GNLFCGLHRYSDKHN | 171 | O76080 | |
| DHFKLYSGFCANHIK | 1196 | Q8IVF5 | |
| FRHGYFCFHEAADQK | 171 | Q9BZQ8 | |
| HTYHVGKQCFFNGVF | 156 | Q496A3 | |
| GNVYCGVHRYSDVHN | 166 | Q6FIF0 | |
| GKAFNCGYHLTQHER | 361 | Q9NQX6 | |
| QRHQSYHIGDFCFQE | 91 | Q8N4W9 | |
| CYHGKTGRVYNVTQH | 56 | P46778 | |
| FHCATGYQLKGARHL | 381 | Q53EL9 | |
| DYLFTKGCFEHIGHA | 211 | O00322 | |
| YDFNHKGVAFRHCNP | 91 | P49190 | |
| DCGKAFCQHVYFTGH | 631 | Q2M218 | |
| CGKAFGHRSSLYQHK | 276 | Q494X3 | |
| CGKGFRYKTHLAQHQ | 526 | Q5TEC3 | |
| QSGDLYRHVRKFHCG | 401 | B2RXF5 | |
| QRFRQFCYGDVHGPH | 46 | O14771 | |
| CGKAFSNRSYLIQHH | 451 | Q9Y2P0 | |
| GIQGCFTAYHLAKHR | 16 | Q9P0Z9 | |
| HIREHNGKGYACFQC | 1116 | Q8NAP3 | |
| FYTIHSCFGGHNEDF | 571 | Q9H7D7 | |
| FCAKVFGHIRVYFGH | 571 | Q7Z4V0 | |
| RHQRIHTGDKYYGCN | 606 | Q86T29 | |
| HKQCGKGLSYRHSFQ | 191 | P15621 | |
| HCGRGFTSATNYKNH | 291 | P36508 | |
| HVVVADAGNHCFKAY | 726 | O75382 | |
| AYFRCEGHVKIYHGN | 371 | Q8NBI6 | |
| CGKAFSRGYHLTQHQ | 296 | Q8N7M2 | |
| CGKAFSRGYHLSQHQ | 436 | Q8N7M2 | |
| ECGKTFGYRSHLNQH | 446 | Q8NB42 |